Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human LILRA2 (CD85h, ILT1) Fc Chimera Recombinant Protein

Click to view available options
Quantity:
1 mg
100 μg
Description
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (1205 μL) be added to the vial to prepare a stock solution of 0.83 mg/mL. Concentration is measured by UV.
Leukocyte Ig-like receptors (LIRs) are a family of immunoreceptors expressed predominantly on monocytes and B cells and at lower levels on dendritic cells and natural killer (NK) cells. All LIRs in subfamily B have an inhibitory function (LILRB1; MIM 604811). LIRs in subfamily A, with short cytoplasmic domains lacking an immunoreceptor tyrosine-based inhibitory motif (ITIM) and with trans membrane regions containing a charged arginine residue, may initiate stimulatory cascades. One member of subfamily A (LILRA3; MIM 604818) lacks a transmembrane region and is presumed to be a soluble receptor.

Specifications
Specifications
Accession Number | Q8N149 |
For Use With (Application) | Control |
Format | Lyophilized |
Formulation | PBS with 0.01% mannitol, 0.01% Tween 80, 5-8% trehalose and no preservative; pH 7.4 |
Gene ID (Entrez) | 11027 |
Molecular Weight (g/mol) | 92.7 kDa |
Name | Human LILRA2 (CD85h, ILT1) Fc Chimera |
Purification Method | SDS-PAGE |
Quantity | 100 μg |
Regulatory Status | RUO |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction